248 related articles for article (PubMed ID: 21984805)
41. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
42. Reappraisal of nodal Epstein-Barr Virus-negative cytotoxic T-cell lymphoma: Identification of indolent CD5
Yamashita D; Shimada K; Takata K; Miyata-Takata T; Kohno K; Satou A; Sakakibara A; Nakamura S; Asano N; Kato S
Cancer Sci; 2018 Aug; 109(8):2599-2610. PubMed ID: 29845715
[TBL] [Abstract][Full Text] [Related]
43. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
[TBL] [Abstract][Full Text] [Related]
44. [Nasal and pharyngeal non-Hodgkin lymphomas and their relationship with Epstein-Barr virus: a report of 158 cases].
He YJ; Jia XS; Hasui K; Wang EH; He AG
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):94-7. PubMed ID: 17493382
[TBL] [Abstract][Full Text] [Related]
45. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis.
Fei Q; Tian XK; Wu J; Zhu HM; Wang Y; Peng FY; Zhang WJ; Yin L; He X
Onco Targets Ther; 2018; 11():997-1004. PubMed ID: 29520150
[TBL] [Abstract][Full Text] [Related]
47. Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases.
Meerbach A; Gruhn B; Egerer R; Reischl U; Zintl F; Wutzler P
J Med Virol; 2001 Oct; 65(2):348-57. PubMed ID: 11536243
[TBL] [Abstract][Full Text] [Related]
48. Adult patient with Epstein-Barr virus (EBV)-associated lymphoproliferative disorder: chronic active EBV infection or de novo extranodal natural killer (NK)/T-cell lymphoma, nasal type?
Ohtsuka R; Abe Y; Sada E; Kiyasu J; Ashikari A; Shiratsuchi M; Nishimura J; Takayanagi R; Ohshima K
Intern Med; 2009; 48(6):471-4. PubMed ID: 19293549
[TBL] [Abstract][Full Text] [Related]
49. Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4 + CD25 + T cell ratio in early stage NK/T cell lymphoma patients may predict worse outcome.
Li PF; Mao YZ; Bai B; Gao Y; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
Ann Hematol; 2018 Dec; 97(12):2381-2389. PubMed ID: 30116872
[TBL] [Abstract][Full Text] [Related]
50. A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.
Hong H; Huang H; Fang X; Wang Z; Ye S; Zhang H; Huang Y; Guo H; Chen X; Liang C; Pu X; Cao Y; Lin S; Li X; Ren Q; Liu Q; Lin T
Am J Hematol; 2019 May; 94(5):E122-E124. PubMed ID: 30690754
[No Abstract] [Full Text] [Related]
51. Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis.
Saleem A; Natkunam Y
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098335
[No Abstract] [Full Text] [Related]
52. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
[TBL] [Abstract][Full Text] [Related]
53. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
54. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
Ruf S; Behnke-Hall K; Gruhn B; Bauer J; Horn M; Beck J; Reiter A; Wagner HJ
J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
[TBL] [Abstract][Full Text] [Related]
55. Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.
Imai A; Takase H; Imadome KI; Matsuda G; Ohnishi I; Yamamoto K; Kudo T; Tanaka Y; Maehara T; Miura O; Arai A
Intern Med; 2017; 56(11):1409-1414. PubMed ID: 28566607
[TBL] [Abstract][Full Text] [Related]
56. Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas.
Zhao D; Hu S; Zhou D; Zhang Y; Wang W; Zhang W
Acta Haematol; 2022; 145(2):132-143. PubMed ID: 34753127
[TBL] [Abstract][Full Text] [Related]
57. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
59. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
[TBL] [Abstract][Full Text] [Related]
60. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene.
Suzumiya J; Ohshima K; Takeshita M; Kanda M; Kawasaki C; Kimura N; Tamura K; Kikuchi M
Leuk Lymphoma; 1999 Nov; 35(5-6):567-78. PubMed ID: 10609794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
